Merck & Co Inc
PAR:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
PAR:MRK
Watchlist
Price: 100.7242 EUR -0.67% Market Closed
Market Cap: 256.9B EUR

Operating Margin

38.1%
Current
Improving
by 1.9%
vs 3-y average of 36.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
38.1%
=
Operating Income
$24.5B
/
Revenue
$64.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
38.1%
=
Operating Income
€24.5B
/
Revenue
$64.2B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
380.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
158.6B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD
Loading...
FR
Sanofi SA
PAR:SAN
95.4B EUR
Loading...
No Stocks Found

Market Distribution

Higher than 94% of companies in the United States of America
Percentile
94th
Based on 14 112 companies
94th percentile
38.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Merck & Co Inc
Glance View

Nestled in the heart of the pharmaceutical industry, Merck & Co., Inc. stands as a titan of innovation and healthcare. Established in 1891, the company has grown and evolved, driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. At the core of Merck’s operations is its commitment to research and development (R&D), which serves as the lifeblood of its product pipeline. With billions poured annually into R&D, Merck seeks to uncover new medical breakthroughs that address unmet medical needs across diverse therapeutic areas, such as oncology, vaccines, infectious diseases, and diabetes. This relentless pursuit of scientific advancement is not only a testament to Merck’s commitment to health but also a critical factor in maintaining its competitive edge in a crowded market. Merck's business model is elegantly straightforward yet highly structured. Primarily, the company's revenue streams are powered by the sales of prescription medications and vaccines that emerge from their exhaustive research efforts. Products like Keytruda, a cancer immunotherapy, and Gardasil, a vaccine for human papillomavirus, are standout performers, championing Merck's ability to penetrate high-value markets and secure regulatory approvals across the globe. Beyond the development and sale of pharmaceuticals, Merck generates additional revenue through collaborations and partnerships with other companies, leveraging co-development and marketing agreements to extend its reach. Underpinning Merck's financial model is its rigorous approach to cost management and strategic acquisitions, which bolster its robust product line-up and keep the engines of growth humming. This strategic orchestration ensures that while Merck fulfills its corporate mission, it also aligns with shareholder interests, reflecting a harmonious balance that has supported its storied legacy.

MRK Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
38.1%
=
Operating Income
$24.5B
/
Revenue
$64.2B
What is Merck & Co Inc's current Operating Margin?

The current Operating Margin for Merck & Co Inc is 38.1%, which is above its 3-year median of 36.2%.

How has Operating Margin changed over time?

Over the last 3 years, Merck & Co Inc’s Operating Margin has increased from 34% to 38.1%. During this period, it reached a low of 34% on Sep 30, 2022 and a high of 38.1% on Sep 30, 2025.

Back to Top